WallStreetZenWallStreetZen

NASDAQ: ENTA
Enanta Pharmaceuticals Inc Stock Ownership - Who owns Enanta Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Enanta Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Matthew Paul KowalskyChief Legal Officer2026-02-121,902$14.25
$27.10kSell
Brendan LuuChief Business Officer2026-02-123,257$14.25
$46.41kSell
Yat Sun OrChief Scientific Officer2026-02-123,413$14.25
$48.64kSell
Jay R. LulyPresident and CEO2026-02-126,155$14.25
$87.71kSell
Scott T. RottinghausChief Medical Officer2026-02-123,413$14.25
$48.64kSell
Tara Lynn KiefferChief Product Strategy Officer2026-02-123,257$14.25
$46.41kSell
Harry R. Trout IiiVice President Finance Principal Financial Officer2025-12-05542$14.23
$7.71kSell
Kathleen S. CappsExecutive Director of Accounting Controller Principal Accounting Officer2025-12-05323$14.23
$4.60kSell
Tara Lynn KiefferChief Product Strategy Officer2025-12-052,106$14.23
$29.97kSell
Jay R. LulyPresident and CEO2025-12-054,743$14.23
$67.49kSell

1 of 3

ENTA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ENTA insiders and whales buy or sell their stock.

ENTA Shareholders

What type of owners hold Enanta Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Helmut Schuhsler19.81%5,761,609$67.58MInsider
Janus Henderson Group PLC13.01%3,784,055$44.39MInstitution
Saints Capital Granite LP12.03%3,497,683$41.03MInsider
Blackrock Inc10.67%3,103,768$36.41MInstitution
Farallon Capital Management LLC9.88%2,871,862$33.69MInstitution
Krensavage Asset Management LLC9.86%2,866,138$33.62MInstitution
Deep Track Capital LP6.73%1,956,867$22.95MInstitution
Shionogi Co Ltd5.50%1,599,760$18.77MInsider
Vanguard Capital Management LLC4.05%1,178,049$13.82MInstitution
Tvm V Life Science Ventures Gmbh Co Kg3.94%1,144,932$13.43MInsider

1 of 3

ENTA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ENTA65.29%34.71%Net Selling
IRD12.84%87.16%Net SellingNet Selling
LRMR55.87%44.13%Net Buying
GLSI11.60%88.40%Net Buying
VSTM61.89%38.11%Net SellingNet Selling
View Top Biotech Stocks

Enanta Pharmaceuticals Stock Ownership FAQ

Who owns Enanta Pharmaceuticals?

Enanta Pharmaceuticals (NASDAQ: ENTA) is owned by 92.07% institutional shareholders, 48.95% Enanta Pharmaceuticals insiders, and 0.00% retail investors. Helmut Schuhsler is the largest individual Enanta Pharmaceuticals shareholder, owning 5.76M shares representing 19.81% of the company. Helmut Schuhsler's Enanta Pharmaceuticals shares are currently valued at $64.99M.

If you're new to stock investing, here's how to buy Enanta Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.